0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Siglec-8

Siglec-8

Brief Information

Name:Sialic acid-binding Ig-like lectin 8
Target Synonym:SIGLEC8,SAF2,Sialoadhesin family member 2,SAF-2,Sialic Acid Binding Ig Like Lectin 8,Sialic Acid Binding Ig-Like Lectin 8,SIGLEC8L,Siglec-8,CDw329,Sialic acid-binding Ig-like lectin 8,MGC59785
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
SI8-H5254 Human Human Siglec-8 Protein, Fc Tag
SI8-H5254-structure
SI8-H5254-sds
SI8-H52H8 Human Human Siglec-8 Protein, His Tag (MALS verified)
SI8-H52H8-structure
SI8-H52H8-sds

Part of Bioactivity data

SI8-H52H8-ELISA
Human Siglec-8, His Tag (Cat. No. ) MALS images

The purity of Human Siglec-8, His Tag (Cat. No. SI8-H52H8) was more than 85% and the molecular weight of this protein is around 102-125 kDa verified by SEC-MALS.

  • Background
    Siglec-8 is also known as SIGLEC8, SAF2, SIGLEC-8, SIGLEC8L and sialic acid binding Ig like lectin 8. Siglec-8 was first identified by CD33 homology screening of ESTs from a cDNA library generated from a patient diagnosed with idiopathic hypereosinophilic syndrome and was originally termed SAF-2 (sialoadhesin family 2). At the tissue level, Siglec-8 mRNA was found to be most highly expressed in lung, PBMCs, spleen, and kidney. Two splice variants of Siglec-8 exist. The initially characterized form contains 431 amino acid residues in total, subsequently, a longer form of Siglec-8, initially termed Siglec-8L. Both forms of Siglec-8 are found in eosinophils and contain a V-set domain with lectin activity and two C2-type Ig repeat domains in the extracellular region.
  • Clinical and Translational Updates
      
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

Synonym Name

Siglec-8,SAF-2,SIGLEC8,SAF2

Background

Siglec-8 is also known as  SIGLEC8, SAF2, SIGLEC-8, SIGLEC8L and sialic acid binding Ig like lectin 8. Siglec-8 was first identified by CD33 homology screening of ESTs from a cDNA library generated from a patient diagnosed with idiopathic hypereosinophilic syndrome and was originally termed SAF-2 (sialoadhesin family 2). At the tissue level, Siglec-8 mRNA was found to be most highly expressed in lung, PBMCs, spleen, and kidney. Two splice variants of Siglec-8 exist. The initially characterized form contains 431 amino acid residues in total, subsequently, a longer form of Siglec-8, initially termed Siglec-8L. Both forms of Siglec-8 are found in eosinophils and contain a V-set domain with lectin activity and two C2-type Ig repeat domains in the extracellular region.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
AK-001 AK-001 Phase 3 Clinical Allakos Respiratory Tract Infections; Nasal Polyps; Urinary Tract Infections; Community Acquired Pneumonia; Dermatitis, Atopic; Hypersensitivity Details
Antolimab AK-002 Phase 3 Clinical Allakos Eosinophilic gastroenteritis (EG); Chronic Urticaria; Mastocytosis, Systemic; Conjunctivitis, Allergic; Eosinophilic Esophagitis; Duodenitis; Keratoconjunctivitis Details

This web search service is supported by Google Inc.

totop